Single- and multiple-dose kinetics of d-fenfluramine in rats given anorectic and toxic doses

References

• Appel N. M., Mitchell W. M. M., Contrera J. F., De Souza E. B. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography. Synapse 1990; 6: 33–44
   PubMed Web of Science ®Google Scholar
• Caccia S., Ballabio M., Guiso G., Rocchetti M., Garattini S. Species differences in the kinetics and metabolism of fenfluramine isomers. Archives Internationales Pharmacodynamie 1982; 258: 15–28
   PubMedGoogle Scholar
• Caccia S., Conforti I., Duchier J., Garattini S. Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given d- and d,l-fenfluramine for 15 days. European Journal of Clinical Pharmacology 1985; 29: 221–224
   PubMed Web of Science ®Google Scholar
• Caccia S., Dagnino G., Garattini S., Guiso G., Madonna R., Zanini M. G. Kinetics of fenfluramine isomers in the rat. European Journal of Drug Metabolism and Pharmacokinetics 1981; 6: 297–301
   PubMedGoogle Scholar
• Campbell D. B., Richards R. P., Caccia S., Garattini S. Stereoselective metabolism and the fate of fenfluramine in animals and man. Development of Drug and Modern Medicines, J. W. Gorrod, G. G. Gibson, M. Mitchard. Ellis Horwood, Chichester 1986; 298–311
   Google Scholar
• Clineschmidt B. V., Zacchei A. G., Totaro J. A., Pflueger A. B., McGuffin J. C., Wishousky T. I. Fenfluramine and brain serotonin. Annals of the New York Academy of Sciences 1978; 305: 222–241
   PubMedGoogle Scholar
• Douglas J. G., Munro J. F. Drug treatment of obesity. Pharmacology and Therapeutics 1982; 18: 351–373
   PubMed Web of Science ®Google Scholar
• Fleisher M. R., Campbell D. B. Fenfluramine overdosage. Lancet 1969; 2: 1306–1307
   PubMedGoogle Scholar
• Fracasso C., Guiso G., Garattini S., Caccia S. Disposition of d-fenfluramine in lean and obese rats. Appetite 1988; 10: 45–55
   PubMed Web of Science ®Google Scholar
• Garattini S., Caccia S. Comparison of the plasma levels of fenfluramine in rats after a toxic dose and in man after a maximal therapeutic dose. Toxicology Letters 1979; 3: 285–290
   Web of Science ®Google Scholar
• Garattini S., Samanin R. Anorectic drugs and brain neurotransmitters. Appetite and Food Intake, T. Silverstone. Dahlem Konferenzen, Berlin 1976; 83–108
   Google Scholar
• Garattini S., Caccia S., Mennini T., Samanin R., Consolo S., Ladinsky H. Biochemical pharmacology of the anorectic drug fenfluramine: A review. Current Medical Research and Opinion 1979; 6(Suppl. 1)15–27
   Google Scholar
• Garattini S., Bizzi A., Caccia S., Mennini T., Samanin R. Progress in assessing the role of serotonin in the control of food intake. Clinical Neuropharmacology 1988; 11(Suppl. 1)8–32
   Google Scholar
• Harvey J. A., McMaster S. E. Fenfluramine: evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin. Psychopharmacology Communications 1975; 1: 217–228
   PubMedGoogle Scholar
• Invernizzi R., Fracasso C., Caccia S., Garattini S., Samanin R. Effects of intracerebroventricular administration of d-fenfluramine and d-norfenfluramine, as a single injection of 2-HR infusion, on serotonin in brain: relationship to concentrations of drugs in brain. Neuropharmacology 1991; 30: 119–123
   PubMed Web of Science ®Google Scholar
• Kalia M. Reversible, short lasting, and dose-dependent effect of D-fenfluramine on neocortical serotonergic axons. Brain Research 1991; 548: 111–125
   PubMed Web of Science ®Google Scholar
• Le Douarec J. C., Neveu C. Pharmacology and biochemistry on fenfluramine. Amphetamines and Related Compounds, E. Costa, S. Garattini. Raven Press, New York 1970; 75–105
   Google Scholar
• Leibowitz S. F., Weiss G. F., Shor-Posner G. Hypothalmic serotonin: Pharmacological, biochemical, and behavioral analyses of its feeding-supressive action. Clinical Neuropharmacology 1988; 11(Suppl. 1)51–71
   PubMedGoogle Scholar
• Mennini T., Bizzi A., Caccia S., Codegoni A., Fracasso C., Frittoli E., Guiso G., Martin Padura I., Taddei C., Uslenghi A., Garattini S. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs. Naunyn-Schmiedeberg's Archives of Pharmacology 1991; 343: 483–490
   PubMed Web of Science ®Google Scholar
• Molliver D. C., Molliver M. E. Anatomic evidence for a neurotoxic effect of (±)-fenfluramine upon serotonergic projections in the rat. Brain Research 1990; 511: 165–168
   PubMed Web of Science ®Google Scholar
• Nathan C., Rolland Y. Pharmacological treatments that affect CNS activity: serotonin. Annals of the New York Academy of Sciences 1987; 499: 277–296
   PubMed Web of Science ®Google Scholar
• Samanin R., Garattini S. The pharmacology of serotoninergic drugs affecting appetite. Nutrition and the Brain, Vol. 8, R. J. Wurtman, J. J. Wurtman. Raven Press, New York 1990; 163–192
   Google Scholar
• Sotelo C. Immunohistochemical study of short- and long-term effects of DL-fenfluramine on the serotonergic innervation of the rat hippocampal formation. Brain Research 1991; 541: 309–326
   PubMed Web of Science ®Google Scholar
• Steranke L. R., Sanders-Bush E. Species differences in the rate of disappearance of fenfluramine and its effects on brain serotonin neurons. Biochemical Pharmacology 1979; 28: 3103–3107
   PubMed Web of Science ®Google Scholar
• Zaczek R., Battaglia G., Culp S., Appel N. M., Contrera J. F., De Souza E. B. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: Pharmacokinetic, dose response, regional specificity and time course data. Journal of Pharmacology and Experimental Therapeutics 1990; 253: 104–112
   PubMed Web of Science ®Google Scholar